TMCnet News
Gen Re Announces 2018 U.S. Group Medical Evidence of Insurability Underwriting Survey ResultsGen Re has released results of its 2018 U.S. Group Medical Evidence of Insurability Underwriting Survey. The survey covers Group Life, LTD and STD products with a focus on how companies staff and process Evidence of Insurability (EOI) applications. It provides companies an opportunity to benchmark their results against those of the industry. Twenty insurance companies participated in this year's survey. Key observations include:
Gen Re, a Berkshire Hathaway Company, is one of the leading life/health and property/casualty reinsurers in the world. Our North American life and health reinsurance company, General Re Life Corporation, has superior financial strength ratings among life and health reinsurers. Gen Re delivers tailor-made reinsurance programs and risk management solutions for the Life, Medicare Supplement, Critical Illness and Individual Disability Income markets. Through our research, we also offer valuable information and insights. For more information, visit www.genre.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20180517005118/en/ |